Checkmate 9kd Cohort A2 Final Analysis: Nivolumab (Nivo) Plus Rucaparib For Chemotherapy (Ct)-Naive Metastatic Castration-Resistant Prostate Cancer (Mcrpc)D. P. Petrylak, J. L. Perez-Gracia,L. Lacombe,D. A. Bastos, H. Mahammedi,E. M. Kwan, S. Zschaeitz,A. J. Armstrong,R. K. Pachynski,J. C. Goh,M. Burotto,G. Gravis,S. L. Mccune,J. C. Vazquez Limon,M. Retz,F. Saad,N. P. Amin, J. Li, K. Unsal-Kacmaz,K. FizaziANNALS OF ONCOLOGY（2021）引用 10|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
